This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors.

Last week, the Federal Trade Commission (FTC) released the redacted version of administrative complaint against the three largest pharmacy benefit managers (PBMs). The FTC rightly calls out how the gross-to-net bubble can raise patients’ out-of-pocket costs, while also acknowledging how rebates can reduce a plan's (but not the patient’s) costs. Apparently, the FTC believes that PBMs’ customers are pretty dumb, because PBMs are able to prevent plans from “appreciating” such healthcare financing dynamics.

Section V.E. of the complaint (starting on page 23) focuses on the PBMs’ alleged unlawful conduct related to preferring high-list/high-rebate insulin products over versions with lower list prices. I thought it would therefore be fun to take the Wayback Machine to November 2021, when I wrote about this specific topic.

Below, you can review my commentary about the warped incentives behind Viatris’ dual-pricing strategy for its interchangeable biosimilar of Lantus. Much of the FTC’s description of the drug channel aligns with my commentary. But before you fist pump too hard for Ms. Khan’s FTC, you should pause to reflect on the agency’s legal theories in light of plans’ revealed preferences.

---

The Food & Drug Administration (FDA) recently approved the first interchangeable biosimilar insulin product: the insulin glargine-yfgn injection from Viatris. Read the FDA’s press release.

Alas, I’m sad to report that the warped incentives baked into the U.S. drug channel will limit the impact of this impressive breakthrough.

Viatris is being forced to launch both a high-priced and a low-priced version of the biosimilar. However, only the high-list/high-rebate, branded version will be available on Express Scripts’ largest commercial formulary. Express Scripts will block both the branded reference product and the lower-priced, unbranded—but also interchangeable—version. Meanwhile, Prime Therapeutics will place both versions on its formularies, leaving the choice up to its plan sponsor clients.

Consequently, many commercial payers will adopt the more expensive product instead of the identical—but cheaper—version. As usual, patients will be the ultimate victims of our current drug pricing system.

Below, I explain the weird economics behind this decision, highlight the negative impact on patients, and speculate on what this all could mean for biosimilars’ future. Until plan sponsors break their addiction to rebates, today’s U.S. drug channel problems will remain.
Read more »

Jul 28, 2024

The Africa in Focus series is a forum for the intellectual and critical analysis of processes and policies from the continent and its engagement with the international community. Through thoughtful and dynamic programming, Africa in Focus brings greater African perspectives into broader policy conversations at HKS.

Details of horse racing coverage on the BBC

Chapter A

So just what is the Modern Age, and how do we get there? First people need to educate themselves in the sense they have power over the University System. It is not the...

The ultra-smooth, shiny finish of "glass hair," which gives tresses a liquid-like lustre, has contributed to making become modern beauty mainstay. It takes beyond just a correct shampoo to achieve this look; it also calls for meticulous planning, the appropriate ingredients,

Verstappen, who has won the last three world championships with Red Bull, said the internal strife had no impact on his performance or comfort within the team.

Experience the thrill of high-octane racing as the Indian Racing Festival 2024 revs up Chennai 

The on-track drama was exciting, and barring a minor incident during the first Indian Racing League race, the event passed off without hiccups.

The contenders across all categories are closely bunched as the fourth round of the INMRC gets under way on September 6

Narain Karthikeyan, in a free-wheeling chat, reflects on his start-up venture, DriveX, the CoASTT circuit he helped develop, and the future of motorsport

The new team is set to participate in various international racing series, starting with the competitive 24H European series in the Porche 992 GT3 cup category

Over 100 entrants, representing 19 teams, will vie for top honours across 19 races at MRF MMSC FMSCI Indian National Motorcycle Racing Championship in Chennai on October 4

Indian actor Ajith Kumar to compete in endurance racing as team owner and principal driver of Ajith Kumar Racing

Lanham, MD : Rowman and Littlefield, 2024.

Bloomington, IN : Solution Tree Press, [2023]

We're putting two of the world's most luxurious racing simulators head-to-head: the ultra-premium $2 million Dynisma racing simulator against the more accessible $63,000 Prodrive model. Is the $2 million price tag justifiable? Join WIRED's deep dive into the features, specifications, design, and performance of each simulator to find out which one reigns supreme.Read more: https://www.wired.com/story/dynisma-worlds-most-expensive-racing-simulator-tested/Director: Anna O'DonohueDirector of Photography: Mateo Akira NotsukeEditor: Estan Esparza; Brady JacksonHost: Jeremy WhiteGuest: Geroge BoothbyCreative Producer: Christie GarciaLine Producer: Joseph BuscemiAssociate Producer: Amy HaskourProduction Manager: Peter BrunetteProduction Coordinator: Kevin BalashCasting Producer: Nicole FordSound Mixer: Michael PanayiotisProduction Assistant: Sasha NovitskiyFact-Checker: Mike DentPost Production Supervisor: Christian OlguinPost Production Coordinator: Ian BryantSupervising Editor: Doug LarsenAdditional Editor: Christopher Jones; Louville MooreAssistant Editor: Justin Symonds

What is a heatwave condition? Why are Indian cities, towns and villages vulnerable both in the hills and the plains? Will notifying it as a State-specific disaster help? Why is it important to have a focused management plan in place?

[U.K.] : Discovery Communications, [2016]

The deadline for the ₹18.6-crore project is December 31, and failure to complete it in time will lead to the Corporation losing the Central share of ₹7.75 crore

This will be the decade of stand up paddleboarding. As the water sport gains ground in both competitive and recreational circles, villages along the Ssouth-eastern coast turn hubs for a homegrown movement

Well past their prime, three athletes from Madurai, P. Senthan, V. Thirunavukkarasu and P. Thiruselvam, qualify for the World Masters Athletics Championship in Perth, Australia.

It is a treasure of information as told by Mahaperiyava

Rural India’s media consumption is increasingly hybrid, with nearly 1 in 2 of rural consumers exposed to both online and offline media.

The Parsi community is the transition zone between the monotheistic and polytheistic mythologies of West and South Asia

With impressive battery life, this one’s all set to win the mid-range smartphone marathon

The Indian Racing Festival, featuring the Indian Racing League and FIA Formula 4 Indian Championships, will begin on August 24 in Chennai

Abarth 595 Competizione has style, roaring speed and powerful engine

Apple and Google’s tech standard is gaining momentum against go-it-alone systems

Robert Jenrick says trial in Isle of Wight will inform decision making on technology

Sri Lanka has gradually begun relaxing curfew as the coronavirus outbreak is now “under control to a certain degree”, Prime Minister Mahinda Rajapaksa

NASCAR will make its return to the track on May 17 at Darlington Raceway – but that doesn't mean fans have been without racing for the past two months.

Williams driver George Russell is enjoying sim racing online while Formula 1 is suspended but admits he doesn't get the same sense of speed or fear.

As interest in the application of plasma medicine -- the use of low-temperature plasma created by an electrical discharge to address medical problems -- continues to grow, so does the need for research advancements proving its capabilities and potential impacts on the health care industry.

E-sports is gaining ground, now is the time to bring tech innovations.

Israel has just reported a potent monoclonal antibody (mAb) against SARS CoV-2. Firms in South Korea, the US are leading mAb trials.

Oracle Corp. Chief Executive Officer Larry Ellison plans to build one to power the Hawaiian island he bought last year. EBay Inc. has one to run a data center. The University of California at San Diego and the federal government have invested tens of millions of dollars in the technology.

Media companies that are starting to allow their programs onto Internet-delivered TV and mobile devices are putting limits on digital rights as a safety hatch if problems arise with the new distribution systems, executives say.

Media companies that are starting to allow their programs onto Internet-delivered TV and mobile devices are putting limits on digital rights as a safety hatch if problems arise with the new distribution systems, executives say.

Email scam targets executives, NSA rates conferencing tools and get ready for COVID tracing apps Welcome to Cyber Security Today. It’s Monday May 4th. I’m Howard Solomon, contributing reporter on cybersecurity for ITWorldCanada.com. To hear the podcast, click on the arrow below: Senior executives of companies around the world should always be careful clicking on…

Members in Spain and Switzerland are developing software for FLIR cameras and building their own versions to protect people’s privacy

With over 3.5 million downloads in the first five days, the app can speed notification of people exposed to COVID-19

Tonio Liuzzi believes his first lap clash with Felipe Massa at the Canadian Grand Prix was a racing accident but admitted it cost him dear

Virgin Racing technical director Nick Wirth was left reflecting on a 'worse-case scenario' of tyre degradation that hampered his team's chances at the Canadian Grand Prix

Teething problems threaten the effectiveness of government ‘test, track and trace’ strategy

• Coronavirus – latest updates
• See all our coronavirus coverage

Just over half the population is likely to download the NHS app developed to track and trace cases of coronavirus, new polling suggests, amid concerns that test result delays could hamper its effectiveness.

A narrow majority of 52% of people told an Opinium poll for the Observer that they were likely to download the app, which alerts users if they have been in close contact with someone who has tested positive for the virus.

Continue reading...